NEU 5.85% $13.37 neuren pharmaceuticals limited

Phase 3 initiated

  1. 258 Posts.
    lightbulb Created with Sketch. 12
    From Acadia earnings...

    Initiated Phase 3 LAVENDER Study of Trofinetide in Rett Syndrome, a Rare Neurodevelopmental Congenital CNS Disorder



 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$13.37
Change
-0.830(5.85%)
Mkt cap ! $1.710B
Open High Low Value Volume
$13.88 $13.91 $13.29 $7.727M 572.1K

Buyers (Bids)

No. Vol. Price($)
6 178 $13.37
 

Sellers (Offers)

Price($) Vol. No.
$13.38 568 7
View Market Depth
Last trade - 14.05pm 08/10/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.